Home En – CIRI-IT

The New Adjuvanted RSV Vaccine (RSVPreF3 OA) for Older Adults: Who Chose It First and Why

Respiratory syncytial virus (RSV) is a name that many associate with acute respiratory infections in children. However, in recent years,…

Maggiori Informazioni

Insights / Other Communicable Infections

Monkeypox

The monkeypox virus belongs to the Poxviridae family, the Chordopoxvirinae subfamily, and the Orthopoxvirus genus. This genus includes many other poxviruses, such as the variola virus,…

Maggiori Informazioni

Other Communicable Infections / Insights

Sexually transmitted diseases

What are Sexually Transmitted Infections (STIs)? STIs, also known as sexually transmitted infections (STIs), are primarily transmitted through unprotected sexual…

Maggiori Informazioni

News_En

2030 Agenda for Sustainable Development

Signed on September 25, 2015, by the governments of the 193 United Nations member states and approved by the UN…

Maggiori Informazioni

News_En

National Vaccination Prevention Plan 2023–2025

The National Vaccination Prevention Plan (PNPV) 2023–2025 was approved by the State-Regions Conference on August 2, 2023. This Plan serves…

Maggiori Informazioni

News_En

Two RSV vaccines approved – 2023

In June 2023, the European Commission authorized a vaccine for active immunization to prevent lower respiratory tract disease (LRTD) caused…

Maggiori Informazioni

News_En

RSV prevention and immunization measures by the Ministry of Health

On March 27, 2024, the Italian Ministry of Health issued a circular outlining prevention and immunization measures against Respiratory Syncytial…

Maggiori Informazioni

News_En

STDs: increase of 1 million case among people aged 15 to 49

A new report from the World Health Organization (WHO) shows that sexually transmitted diseases (STDs) are on the rise in…

Maggiori Informazioni

Influenza / News_En

Prevention and control of Influenza – 2024–2025 Season

The 2023–2024 influenza season, was characterised by a high rate of influenza-like illnesses (ILI) and/or acute respiratory infections (ARI), mostly…

Maggiori Informazioni

News_En

Nirsevimab: a new opportunity for RSV prevention in Newborns

Respiratory Syncytial Virus (RSV) is one of the leading causes of lower respiratory tract infections and can lead to bronchiolitis…

Maggiori Informazioni

News_En

Avian Influenza and the New mRNA Vaccine

Avian influenza, particularly the H5N1 strain, continues to pose a serious threat to global public health. This virus, while primarily…

Maggiori Informazioni

News_En

Antibiotic Resistance: a responsible approach

With the arrival of the autumn and winter seasons, there is a significant increase in respiratory infections such as colds,…

Maggiori Informazioni

News_En

Respiratory infections, 2024–2025 record season: over 16 million Italians affected

Whithin Week 17 of 2025, the RespiVirNet influenza surveillance system has concluded, marking a record-breaking season. According to the latest…

Maggiori Informazioni

News_En / Publications

First Italian real-world results on the tolerability of the adjuvanted RSV vaccine in adults aged 60 and over published in Vaccine: X

The study titled “Enhanced safety surveillance of the adjuvanted respiratory syncytial virus vaccine among Italian older adults” was recently published…

Maggiori Informazioni

News_En / Other Communicable Infections

Measles in Italy in 2025: between the Milan outbreak and national challenge

Measles, one of the most contagious infectious diseases, continues to circulate in Italy, proving it is far from a relic…

Maggiori Informazioni

SPECIALE COVID-19